Assignee
SUZHOU ZANRONG PHARMA LTD
CN·2 granted patents·3 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0159US2023293533A1Quinazoline derivatives as antitumor agentsSUZHOU ZANRONG PHARMA LTD·Filed 2023·Application pending·0 cites
- 0252US2024376123A1Kras g12d inhibitors and uses thereofSUZHOU ZANRONG PHARMA LTD·Filed 2022·Application pending·0 cites
- 0350US2024207263A1Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereofSUZHOU ZANRONG PHARMA LTD·Filed 2022·Application pending·0 cites
- 0444US11723908B2Quinazoline derivatives as antitumor agentsSUZHOU ZANRONG PHARMA LTD·Filed 2019·Granted Aug 15, 2023·0 cites·36 claims
- 0539US12226414B21-isopropyl-3-methyl-8-(pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c] cinnolin-2-one as selective modulators of ataxia telangiectasia mutated (ATM) kinase and uses thereofSUZHOU ZANRONG PHARMA LTD·Filed 2019·Granted Feb 18, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when SUZHOU ZANRONG PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →